【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 16
2 Introduction 17
2.1 Bone Grafts and Substitutes Overview 17
3 Products under Development 18
3.1 Bone Grafts and Substitutes – Pipeline Products by Stage of Development 18
3.2 Bone Grafts and Substitutes – Pipeline Products by Segment 19
3.3 Bone Grafts and Substitutes – Pipeline Products by Territory 20
3.4 Bone Grafts and Substitutes – Pipeline Products by Regulatory Path 21
3.5 Bone Grafts and Substitutes – Pipeline Products by Estimated Approval Date 22
3.6 Bone Grafts and Substitutes – Ongoing Clinical Trials 23
4 Bone Grafts and Substitutes – Pipeline Products under Development by Companies 24
4.1 Bone Grafts and Substitutes Companies – Pipeline Products by Stage of Development 24
4.2 Bone Grafts and Substitutes – Pipeline Products by Stage of Development 28
5 Bone Grafts and Substitutes Companies and Product Overview 32
5.1 aap Implantate AG Company Overview 32
5.1.1 aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview 32
5.2 Accelerated Orthopedic Technologies, Inc. Company Overview 35
5.2.1 Accelerated Orthopedic Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.3 Adaptaide Inc. Company Overview 36
5.3.1 Adaptaide Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.4 Adocia Company Overview 37
5.4.1 Adocia Pipeline Products & Ongoing Clinical Trials Overview 37
5.5 Advanced Biologics, LLC Company Overview 41
5.5.1 Advanced Biologics, LLC Pipeline Products & Ongoing Clinical Trials Overview 41
5.6 Agenta Biotechnologies, Inc. Company Overview 42
5.6.1 Agenta Biotechnologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.7 Allergan, Inc. Company Overview 43
5.7.1 Allergan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.8 Alphatec Holdings, Inc. Company Overview 46
5.8.1 Alphatec Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.9 Amedica Corporation Company Overview 48
5.9.1 Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview 48
5.10 Anika Therapeutics, Inc. Company Overview 50
5.10.1 Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.11 ApaTech Limited (Inactive) Company Overview 53
5.11.1 ApaTech Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53
5.12 Aperion Biologics Corporation Company Overview 55
5.12.1 Aperion Biologics Corporation Pipeline Products & Ongoing Clinical Trials Overview 55
5.13 Arthro Kinetics AG Company Overview 62
5.13.1 Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 Aursos, Inc Company Overview 63
5.14.1 Aursos, Inc Pipeline Products & Ongoing Clinical Trials Overview 63
5.15 Berkeley Advanced Biomaterials, Inc. Company Overview 64
5.15.1 Berkeley Advanced Biomaterials, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.16 Bio2 Technologies, Inc. Company Overview 67
5.16.1 Bio2 Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.17 Bioactive Bone Substitutes Ltd. Company Overview 68
5.17.1 Bioactive Bone Substitutes Ltd. Pipeline Products & Ongoing Clinical Trials Overview 68
5.18 Bioregeneration Technologies, Inc Company Overview 69
5.18.1 Bioregeneration Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.19 Bio-Scaffold International Pte Ltd Company Overview 70
5.19.1 Bio-Scaffold International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 70
5.20 BioSET, Inc Company Overview 74
5.20.1 BioSET, Inc Pipeline Products & Ongoing Clinical Trials Overview 74
5.21 Bioventus LLC Company Overview 81
5.21.1 Bioventus LLC Pipeline Products & Ongoing Clinical Trials Overview 81
5.22 Body Organ Biomedical Corp. Company Overview 83
5.22.1 Body Organ Biomedical Corp. Pipeline Products & Ongoing Clinical Trials Overview 83
5.23 Bone Solutions, Inc. Company Overview 85
5.23.1 Bone Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
5.24 BoneGrafix, Inc. Company Overview 90
5.24.1 BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.25 BoneSupport AB Company Overview 91
5.25.1 BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview 91
5.26 Calcitec, Inc. Company Overview 95
5.26.1 Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.27 Cellright Technologies, LLC Company Overview 96
5.27.1 Cellright Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 96
5.28 CeraPedics, Inc. Company Overview 97
5.28.1 CeraPedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.29 Chinese University of Hong Kong Company Overview 104
5.29.1 Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 104
5.30 Citrics Biomedical, LLC Company Overview 105
5.30.1 Citrics Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview 105
5.31 CollPlant Ltd. Company Overview 106
5.31.1 CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview 106
5.32 ConMed Corporation Company Overview 108
5.32.1 ConMed Corporation Pipeline Products & Ongoing Clinical Trials Overview 108
5.33 CoreBone Ltd. Company Overview 110
5.33.1 CoreBone Ltd. Pipeline Products & Ongoing Clinical Trials Overview 110
5.34 ElutInc Company Overview 111
5.34.1 ElutInc Pipeline Products & Ongoing Clinical Trials Overview 111
5.35 EpiBone Company Overview 112
5.35.1 EpiBone Pipeline Products & Ongoing Clinical Trials Overview 112
5.36 Exactech, Inc. Company Overview 113
5.36.1 Exactech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 113
5.37 Graftoss Limited Company Overview 115
5.37.1 Graftoss Limited Pipeline Products & Ongoing Clinical Trials Overview 115
5.38 Graftys SAS Company Overview 116
5.38.1 Graftys SAS Pipeline Products & Ongoing Clinical Trials Overview 116
5.39 Inion Oy Company Overview 122
5.39.1 Inion Oy Pipeline Products & Ongoing Clinical Trials Overview 122
5.40 Innovia LLC Company Overview 123
5.40.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 123
5.41 Innovoss Inc. Company Overview 124
5.41.1 Innovoss Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.42 Integra LifeSciences Holdings Corporation Company Overview 125
5.42.1 Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview 125
5.43 ISTO Technologies, Inc. Company Overview 127
5.43.1 ISTO Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 127
5.44 Jellagen Pty Ltd Company Overview 128
5.44.1 Jellagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 128
5.45 kasios sas Company Overview 129
5.45.1 kasios sas Pipeline Products & Ongoing Clinical Trials Overview 129
5.46 Kensey Nash Corporation (Inactive) Company Overview 130
5.46.1 Kensey Nash Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 130
5.47 Kytogenics Pharmaceuticals, Inc. Company Overview 131
5.47.1 Kytogenics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 131
5.48 Lacerta Technologies GmbH Company Overview 132
5.48.1 Lacerta Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 132
5.49 Mariel Therapeutics, Inc. Company Overview 134
5.49.1 Mariel Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 134
5.50 Maxigen Biotech Inc. Company Overview 135
5.50.1 Maxigen Biotech Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
5.51 Medtronic plc Company Overview 138
5.51.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 138
5.52 Meta Biomed Co., Ltd. Company Overview 142
5.52.1 Meta Biomed Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 142
5.53 Miromatrix Medical Inc. Company Overview 144
5.53.1 Miromatrix Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 144
5.54 N2 Biomedical Company Overview 145
5.54.1 N2 Biomedical Pipeline Products & Ongoing Clinical Trials Overview 145
5.55 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview 146
5.55.1 National Center of Innovation for Biomaterials in Orthopaedic Research Pipeline Products & Ongoing Clinical Trials Overview 146
5.56 Noraker Company Overview 147
5.56.1 Noraker Pipeline Products & Ongoing Clinical Trials Overview 147
5.57 NovaBone Products, LLC. Company Overview 149
5.57.1 NovaBone Products, LLC. Pipeline Products & Ongoing Clinical Trials Overview 149
5.58 Nutech Medical, Inc Company Overview 150
5.58.1 Nutech Medical, Inc Pipeline Products & Ongoing Clinical Trials Overview 150
5.59 NuVasive, Inc. Company Overview 151
5.59.1 NuVasive, Inc. Pipeline Products & Ongoing Clinical Trials Overview 151
5.60 Orthogen LLC Company Overview 155
5.60.1 Orthogen LLC Pipeline Products & Ongoing Clinical Trials Overview 155
5.61 OssiFi, Inc. Company Overview 156
5.61.1 OssiFi, Inc. Pipeline Products & Ongoing Clinical Trials Overview 156
5.62 OsteoNovus, LLC Company Overview 157
5.62.1 OsteoNovus, LLC Pipeline Products & Ongoing Clinical Trials Overview 157
5.63 PolyPid, Ltd. Company Overview 158
5.63.1 PolyPid, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 158
5.64 Promimic AB Company Overview 160
5.64.1 Promimic AB Pipeline Products & Ongoing Clinical Trials Overview 160
5.65 ReCaPP Company Overview 161
5.65.1 ReCaPP Pipeline Products & Ongoing Clinical Trials Overview 161
5.66 RepRegen Ltd. (Inactive) Company Overview 162
5.66.1 RepRegen Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 162
5.67 Revivicor, Inc. Company Overview 164
5.67.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 164
5.68 RTI Surgical, Inc. Company Overview 166
5.68.1 RTI Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 166
5.69 Sanofi Company Overview 168
5.69.1 Sanofi Pipeline Products & Ongoing Clinical Trials Overview 168
5.70 SIRAKOSS Limited Company Overview 170
5.70.1 SIRAKOSS Limited Pipeline Products & Ongoing Clinical Trials Overview 170
5.71 Soft Tissue Regeneration, Inc. Company Overview 171
5.71.1 Soft Tissue Regeneration, Inc. Pipeline Products & Ongoing Clinical Trials Overview 171
5.72 Soteira Inc. Company Overview 175
5.72.1 Soteira Inc. Pipeline Products & Ongoing Clinical Trials Overview 175
5.73 Spineway Company Overview 176
5.73.1 Spineway Pipeline Products & Ongoing Clinical Trials Overview 176
5.74 SurgaColl Technologies Ltd Company Overview 178
5.74.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 178
5.75 TBF Genie Tissulaire Company Overview 181
5.75.1 TBF Genie Tissulaire Pipeline Products & Ongoing Clinical Trials Overview 181
5.76 The Johns Hopkins University Company Overview 183
5.76.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 183
5.77 Tissue Regeneration Systems, Inc. Company Overview 184
5.77.1 Tissue Regeneration Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.78 Trinity College Dublin Company Overview 185
5.78.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 185
5.79 University of California, San Diego Company Overview 186
5.79.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 186
5.80 University of Edinburgh Company Overview 187
5.80.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 187
5.81 University of Memphis Company Overview 189
5.81.1 University of Memphis Pipeline Products & Ongoing Clinical Trials Overview 189
5.82 University of Nottingham’s School Of Pharmacy Company Overview 190
5.82.1 University of Nottingham’s School Of Pharmacy Pipeline Products & Ongoing Clinical Trials Overview 190
5.83 University of Pecs Company Overview 191
5.83.1 University of Pecs Pipeline Products & Ongoing Clinical Trials Overview 191
5.84 University of South Florida Company Overview 192
5.84.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 192
5.85 Wayne State University Company Overview 193
5.85.1 Wayne State University Pipeline Products & Ongoing Clinical Trials Overview 193
5.86 Wound Management Technologies, Inc. Company Overview 194
5.86.1 Wound Management Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 194
5.87 Wright Medical Group, Inc. Company Overview 196
5.87.1 Wright Medical Group, Inc. Pipeline Products & Ongoing Clinical Trials Overview 196
5.88 X-spine Systems, Inc. Company Overview 203
5.88.1 X-spine Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 203
5.89 Xtant Medical Holdings, Inc. Company Overview 204
5.89.1 Xtant Medical Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 204
6 Bone Grafts and Substitutes- Recent Developments 207
7 Appendix 267
7.1 Methodology 267
7.2 About GlobalData 269
7.3 Contact Us 270
7.4 Disclaimer 270
【レポート販売概要】
■ タイトル：世界における骨移植片/骨代用材の製品パイプライン動向2015■ 英文：Bone Grafts and Substitutes - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0079EPD
■ 調査対象地域：グローバル
- Candax Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Candax Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Candax Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- Cystic Fibrosis Therapeutics：市場分析及び予測（～2017）OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017 Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick, sticky mucus which clogs the lungs and leads to life-threatening lung infections; and obstructs pancreatic enzyme secretions that are essential for the body to break down and absorb nutrients. CF patie …
- 酵母成分の世界市場：アプリケーション別（飼料、食品）、種類別（自己分解物、抽出物、ベータグルカン、誘導体）、ベンダー別、セグメント予測The global yeast ingredients market size is expected to reach USD 3.5 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 8.0% during the forecast period. Rising usage of yeast ingredients in the food industry, coupled with government initiatives to promote use of these ingredients in food products, is expected to boost the growth of the market over the fo …
- ピック病（Pick’s Disease）：グローバル臨床試験動向（2014年上半期）Pick's Disease Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Pick's Disease Global Clinical Trials Review, H1, 2014" provides data on the Pick’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pick’s Disease It includes an overview of the trial numbers and their recruitment status as per …
- 建築・建設用アルミニウムの世界市場：アルミニウム押出製品、アルミニウムRFP、アルミニウム鋳物、アルミニウム粉末About the Aluminum Market for Building and Construction Sector The aluminum industry value chain consists of both upstream and downstream sectors. Operations of upstream sectors include mining (extraction of bauxite) and refining (bauxite to alumina). The commonly used process for extracting bauxite is the Bayer process. The downstream operations involve casting, smelting, and fabricating the refi …
- 世界の油脂市場動向：ニュース・イベント（2014年5月）Synopsis The report provides a review of the latest news and key events in the global oils and fats market during May 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global oils and fats market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the gl …
- 空気分離装置の世界市場予測（～2026）：分離方法別（低温、非低温）、ガス種類別（窒素、酸素、アルゴン）、エンドユーザー別（鉄鋼、石油・ガス、化学、医療）、地域別“The global air separation plant market is projected to grow at a CAGR of 5.3% from 2016 to 2026”The global air separation plant market is projected to reach USD 7.27 billion by 2026, at a CAGR of 5.3% from 2016 to 2026. The major market is the growing demand for industrial gases with high purity level from key end-use industries. The growth is also driven by the stringent safety and environmental …
- ガラス食器の世界市場2019-2023About this market Launch of smartphone-based applications by vendors to drive market growth. Smartphone applications are becoming a powerful medium to deliver information to consumers. As these applications provide a better customer interface and extensive information about products. it leads to enhanced consumer experience and creates a factor of differentiation about the brand. As there are diff …
- 世界の六方晶窒化ホウ素市場2015The Global Hexagonal Boron Nitride Industry Report 2015 is a professional and in-depth study on the current state of the Hexagonal Boron Nitride industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hexagonal Boron Nitride market analyses is provided for the international markets including development t …
- スコッチ・ウイスキーの世界市場About Scotch WhiskyScotch whisky is produced in Scotland. It is produced, packaged, and labeled as per SWR 2009. Scotch whisky is produced in five regions in Scotland: Highland, Lowland, Islay, Speyside, and Campbeltown. Technavio’s analysts forecast the global scotch whisky market to grow at a CAGR of 2.35% during the period 2017-2021. [Covered in this report] The report covers the present scenar …
- 薬剤溶出バルーン(DEB)：グローバル市場分析と予測MediPoint: Drug-Eluting Balloons - Global Analysis and Market Forecasts Summary GlobalData has released its medical devices report, “MediPoint: Drug-Eluting Balloons - Global Analysis and Market Forecasts”. The report is an essential source of information and analysis on the global drug-eluting balloons (DEB) market. The report provides in-depth insight into the use of DEB for coronary and periphe …
- Truvada (HIV)：市場予測と分析（～2022）Truvada (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Truvada (HIV) - Forecast and Market Analysis to 2022”. Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral therapy (ART) has transformed the face of HIV/AIDS from a dea …
- 外傷痛：治療薬の治験動向（2014年下半期）Traumatic Pain Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Traumatic Pain Global Clinical Trials Review, H2, 2014" provides data on the Traumatic Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Traumatic Pain. It includes an overview of the trial numbers and their recruitment status as per …
- 世界のバンキング及び決済スマートカード市場動向（2012-2016）TechNavio's analysts forecast the Global Banking and Payment Smart Cards market to grow at a CAGR of 12.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing need for a tamper-resistant payment system. The Global Banking and Payment Smart Cards market has also been witnessing an increasing adoption of near-field communication payments. Ho …
- 電動UAV（無人機）の世界市場About Electric Unmanned Aerial Vehicles UAVs, also referred to as drones, are aerial vehicles without a human pilot aboard. The vehicle is controlled either autonomously by an on-board computer or by a remote control from the ground or on another vehicle. UAVs range in sizes. Large UAVs are used for tactical missions that are powered by internal combustion engines. Small electric powered UAVs are …
